SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 206 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $62 | -99.9% | 3,688 | -10.0% | 0.00% | 0.0% |
| Q3 2022 | $70,000 | 0.0% | 4,098 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $70,000 | 0.0% | 4,098 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $70,000 | +2233.3% | 4,098 | +1889.3% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 206 | -17.6% | 0.00% | – |
| Q1 2021 | $3,000 | -25.0% | 250 | -7.1% | 0.00% | – |
| Q4 2020 | $4,000 | +300.0% | 269 | +31.9% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 204 | +30.8% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 156 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 156 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 156 | -1.9% | 0.00% | – |
| Q3 2019 | $1,000 | -87.5% | 159 | -68.2% | 0.00% | – |
| Q3 2018 | $8,000 | +300.0% | 500 | +316.7% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 120 | +7.1% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 112 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 112 | +6.7% | 0.00% | – |
| Q3 2017 | $2,000 | – | 105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |